Cure My Disease

Don't miss your cure!

 Log in / Sign up

Chatbot vs. standard referral: which gets you therapy quicker?

NCT ID NCT05678764

Knowledge-focused Sponsor: Limbic Limited Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether a conversational information collection tool (like a chatbot) can improve access to talk therapy for mental health issues. Over 100,000 people participated. Researchers compared depression and anxiety scores, wait times, and dropout rates between those who used the tool and those who used other referral methods.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

104,874 people

The number who actually took part.

Started

Jun 2023

Finished

Oct 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

All patients who refer to the talk therapy services that use the conversational information collection tool.

Ages

16 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Participant meets minimum age requirements for the talk therapy service Participant's registered GP is within the talk therapy service's CCG catchment area Exclusion Criteria: * Participants who are in crisis (defined by requiring urgent care or being at an urgent risk of harm)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Mental health issue are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Mental health issue

Contacts and locations

Locations

  • Essex Partnership University NHS Foundation Trust

    Epping, United Kingdom

  • Lincolnshire Partnership NHS Foundation Trust

    Lincoln, LN1 1FS, United Kingdom

  • Surrey and Borders Partnership NHS Foundation Trust

    Leatherhead, Surrey, KT22 9AD, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.